ALDX Quote, Trading Chart, Aldeyra Therapeutics Inc.
home / stock / aldx / aldx quote
$11.92 Last:
0.0% Change Percent:
$12.1 Open:
$11.92 Previous Close:
$12.1999 High:
$11.8 Low:
806,236 Volume:
06/21/2021 04:42:36 am Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
ALDX Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2021-06-21 | 12.1 | 11.92 | 12.1999 | 11.8 | 806,236 |
| 2021-06-18 | 11.93 | 11.92 | 12.23 | 11.76 | 1,430,026 |
| 2021-06-17 | 11.89 | 12.15 | 12.29 | 11.87 | 429,660 |
| 2021-06-16 | 11.96 | 11.95 | 12.11 | 11.52 | 608,294 |
| 2021-06-15 | 12.3 | 12.04 | 12.38 | 11.915 | 603,927 |
| 2021-06-14 | 12.44 | 12.29 | 12.54 | 12.16 | 883,129 |
| 2021-06-11 | 12.53 | 12.34 | 12.73 | 12.27 | 324,252 |
| 2021-06-10 | 12.58 | 12.41 | 12.78 | 12.3 | 492,045 |
| 2021-06-09 | 13.13 | 12.57 | 13.175 | 12.42 | 1,231,049 |
| 2021-06-08 | 13 | 12.97 | 13.06 | 12.66 | 735,274 |
| 2021-06-07 | 12.72 | 12.91 | 13.18 | 12.63 | 1,084,121 |
| 2021-06-04 | 12.59 | 12.64 | 12.89 | 12.49 | 476,756 |
| 2021-06-03 | 12.5 | 12.49 | 12.66 | 12.33 | 386,557 |
| 2021-06-02 | 12.25 | 12.54 | 12.54 | 12.15 | 640,994 |
| 2021-06-01 | 12.53 | 12.24 | 12.61 | 12.21 | 426,625 |
| 2021-05-31 | 11.89 | 12.52 | 12.68 | 11.82 | 712,500 |
| 2021-05-28 | 11.89 | 12.52 | 12.68 | 11.82 | 709,859 |
| 2021-05-27 | 11.43 | 11.85 | 11.87 | 11.09 | 661,516 |
| 2021-05-26 | 11.34 | 11.42 | 11.56 | 11.22 | 846,788 |
| 2021-05-25 | 11.4 | 11.36 | 11.69 | 11.28 | 481,337 |
Aldeyra Therapeutics Inc. Company Name:
ALDX Stock Symbol:
NASDAQ Market:
Aldeyra Therapeutics Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
-
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that Todd C. Brady, M.D., Ph.D., President and Chief Executive Officer of Aldeyra, will participate in a fireside chat at the Jefferies Virtual Healthcare Conference on Wednesday, June 2, 2021, at 4:30 p.m. ET. ...
-
Image source: The Motley Fool. Aldeyra Therapeutics (NASDAQ: ALDX) Q1 2021 Earnings Call May 06, 2021 , 8:00 a.m. ET Operator Continue reading For further details see: Aldeyra Therapeutics (ALDX) Q1 2021 Earnings Call Transcript
-
Recently Announced Phase 3 INVIGORATE Clinical Trial Results Indicated Statistically Significant Activity of Reproxalap in Ocular Itching and Redness Associated with Allergic Conjunctivitis Top-Line Results from Phase 3 TRANQUILITY and TRANQUILITY-2 Trials of Reproxalap in D...